BeyondAirInc . (NASDAQ: XAIR) is one of 128 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare BeyondAirInc . to related companies based on the strength of its institutional ownership, profitability, earnings, valuation, analyst recommendations, dividends and risk.
Valuation & Earnings
This table compares BeyondAirInc . and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|BeyondAirInc .||$7.72 million||-$6.56 million||-5.87|
|BeyondAirInc . Competitors||$1.41 billion||$143.85 million||-12.17|
Institutional and Insider Ownership
5.4% of BeyondAirInc . shares are held by institutional investors. Comparatively, 50.4% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 15.4% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Risk & Volatility
BeyondAirInc . has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500. Comparatively, BeyondAirInc .’s rivals have a beta of 0.99, suggesting that their average stock price is 1% less volatile than the S&P 500.
This table compares BeyondAirInc . and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|BeyondAirInc . Competitors||-674.02%||-624.75%||-22.21%|
This is a summary of recent ratings and target prices for BeyondAirInc . and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|BeyondAirInc . Competitors||959||3197||5410||288||2.51|
As a group, “Surgical & medical instruments” companies have a potential upside of 17.72%. Given BeyondAirInc .’s rivals higher probable upside, analysts plainly believe BeyondAirInc . has less favorable growth aspects than its rivals.
BeyondAirInc . rivals beat BeyondAirInc . on 7 of the 10 factors compared.
BeyondAirInc . Company Profile
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York.
Receive News & Ratings for BeyondAirInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondAirInc . and related companies with MarketBeat.com's FREE daily email newsletter.